Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the safety and tolerability of treatment
with PROVIGIL in children and adolescents with excessive sleepiness (ES) associated with
narcolepsy or obstructive sleep apnea/hypopnea syndrome (OSAHS), when administered for up to
6 months.